Skip to content
HOME
About Yuhan
History
History
-
2020
- Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
- All Star 17 (first in Pharmaceuticals) 17 consecutive years
- Yuhan Corporation, 2019 Revenue 1.4804 trillion won
-
2019
- Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
- All Star 16 (first in Pharmaceuticals) 16 consecutive years
- Yuhan Corporation, 2018 Revenue 1.5188 trillion won (#1 in the industry)
-
2018
- Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
- All Star 15 (first in Pharmaceuticals) 15 consecutive years
- Yuhan Corporation, 2017 Revenue 1.4622 trillion won (#1 in the industry)
-
2017
- Received Korean Government’s ($200 million USD) Export Tower Award
- Received 2017 The 41st National Productivity Award from Korean President
- New Il-Han Award (Prof. Kim. H. S. Yonsei Univ)
-
2016
- The ninety(90) years of company establishment
- All Star 13 (first in Pharmaceuticals) 13 consecutive years
-
2015
- All Star 12 (first in Pharmaceuticals) 12 consecutive years
-
2014
- All Star 11 (first in Pharmaceuticals) 11 consecutive years
-
2013
- Yuhan Corporation is recognized as the most respected company in Korea by the Korean Management Association
- Received Korean government’s ($100 million USD) Export Tower Award
- First in Korean pharmaceutical industry to receive 10th No-Accident certificate
-
2012
- Established strategic alliance with HanAll Biopharma Co., Ltd., of Seoul, Korea
- Received Innovative Pharmaceutical Enterprise certification from the Korean Ministry of Health and Welfare
-
2011
- Cooperative development contract with Esoltek investment for degenerative arthritis medication
-
2010
- Revanex Out-Licensing to China
- Ochang plant received KOSHA 18001/OHAS 18001 certification
- Received 2010 Labor and Culture Award from Korean Prime Minister
YH4808